✦ LIBER ✦

Non-random chromosomal differences between seminoma and non-seminoma

✍ Scribed by J.W. Oosterhuis; B. de Jong; S.M.M.J. Castedo; A. Dam; D.Th. Sleijfer; H.Schraffordt Koops

Book ID: 113395684
Publisher: Elsevier Science
Year: 1989
Tongue: English
Weight: 80 KB
Volume: 27
Category: Article
ISSN: 0922-3371
DOI: 10.1016/0922-3371(89)90487-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk factors for testicular cancer – dif

Risk factors for testicular cancer – differences between pure non-seminoma and mixed seminoma/non-seminoma?

✍ E. L. Aschim; T. B. Haugen; S. Tretli; A. K. Daltveit; T. Grotmol 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

New markers for testicular non-seminoma

New markers for testicular non-seminoma and seminoma: HA and HAS-1

✍ S. Hautmann; G. Schroeder; F. Civantos; R. Gnann; M. Soloway; H. Huland; V. Loke 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 184 KB

Comparative genomic hybridization of mic

Comparative genomic hybridization of microdissected samples from different stages in the development of a seminoma and a non-seminoma

✍ Looijenga, Leendert H. J.; Rosenberg, Carla; van Gurp, Ruud J. H. L. M.; Geelen, 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

Human testicular germ cell tumours (TGCTs) of adolescents and adults, both seminomas and non-seminomas, originate from intratubular germ cell neoplasia (IGCN). Comparative genomic hybridization (CGH) was applied to microdissected samples from different stages of the development of a seminoma and a m

HLA-antigen distribution in seminoma, HC

HLA-antigen distribution in seminoma, HCG-positive seminoma and non-seminomatous tumours of the testis

✍ Kratzik, C. ;Aiginger, P. ;Kuzmits, R. ;Spona, J. ;Kirnbauer, M. ;Seiser, A. ;Ma 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 373 KB

Histopathological and molecular features

Histopathological and molecular features of late relapses in non-seminomas

✍ Frank Mayer; Hendrik Wermann; Peter Albers; Hans Stoop; Ad J.M. Gillis; Jörg T. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 433 KB

Surgery versus surveillance in stage I n

Surgery versus surveillance in stage I non-seminoma testicular cancer

✍ Dirk J.A. Sonneveld; Heimen Schraffordt Koops; Dirk Th Sleijfer; Harald J. Hoeks 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Today, the standard treatment for patients with clinical Stage I non-seminomatous testicular germ cell tumors (NSTGCT) following orchidectomy is either primary retroperitoneal lymph node dissection (RPLND) or close surveillance with cisplatin-based polychemotherapy in case of a relapse. Both treatme